EUVIMEDSkopri EUVIMED
LeserbriefKommentar

Treatment with sodium‐glucose cotransporter 2 inhibitors and risk of lower‐limb amputations

Ivan Tkáč iD, Miriam Kozárová, Alena Stančáková Yaluri, Martin Javorský

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15775 ↗

At a glance

Leserbrief in Diabetes, Obesity and Metabolism, 2024. Written by Ivan Tkáč and 3 co-authors. Institution: Department of Internal Medicine 4, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia. Major MEDLINE topics: Sodium-Glucose Transporter 2 Inhibitors, Amputation, Surgical, Diabetes Mellitus, Type 2, Diabetic Foot. 12 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.15775. Our data will be available on request.

Subjects

MeSH terms (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsAmputation, SurgicalDiabetes Mellitus, Type 2Diabetic FootHumansLower ExtremityMaleFemaleRisk FactorsMiddle AgedAgedHypoglycemic Agents

Substances

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic Agents

Authors and institutions

  • Department of Internal Medicine 4, Faculty of Medicine, Pavol Jozef Šafárik University, Košice, Slovakia.
  • Louis Pasteur University Hospital, Košice, Slovakia.

ORCID profiles: Ivan Tkáč

Cite

APA

Tkáč, I., Kozárová, M., Stančáková Yaluri, A., & Javorský, M. (2024). Treatment with sodium‐glucose cotransporter 2 inhibitors and risk of lower‐limb amputations. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15775

Vancouver

Tkáč I, Kozárová M, Stančáková Yaluri A, Javorský M. Treatment with sodium‐glucose cotransporter 2 inhibitors and risk of lower‐limb amputations. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15775

BibTeX
@article{Tk2024,
  author = {Tkáč, Ivan and Kozárová, Miriam and Stančáková Yaluri, Alena and Javorský, Martin},
  title = {Treatment with sodium‐glucose cotransporter 2 inhibitors and risk of lower‐limb amputations},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15775}
}
Start for free →